Sort
23,748 grants matching “melanoma”
PEPTIDE TARGETING OF IL12 TO MALIGNANT ENDOTHELIUM
$194,400University Of Wisconsin Madison · R01 · FY2002 · CA
Glycosylation as a Regulator of Tropism of Melanoma Metastasis - Resubmission - 1
$194,400Praveen Agrawal · Albert Einstein College Of Medicine · K22 · FY2022 · CA
PEPTIDE TARGETING OF IL12 TO MALIGNANT ENDOTHELIUM
$194,400University Of Wisconsin Madison · R01 · FY2001 · CA
Enhancing motivation to quit smoking via self-help intervention targeted to cancer type: A pilot RCT
$194,398Ursula Martinez Pradeda · Utah State Higher Education System--University Of Utah · K22 · FY2025 · CA
Enhancing motivation to quit smoking via self-help intervention targeted to cancer type: A pilot RCT
$194,398Ursula Martinez Pradeda · University Of Utah · K22 · FY2024 · CA
Non-invasive detection of malaria parasites in vitro and in Cameroonian adults
$194,357Sunil Parikh · Yale University · R21 · FY2023 · AI
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
$194,344Georg T Wondrak · University Of Arizona · P01 · FY2022 · CA
DNA-Methylation Profiling from Fixed Melanocytic Tissues
$194,329Nancy E Thomas · Univ Of North Carolina Chapel Hill · R21 · FY2009 · CA
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination
$194,308Prabhani Atukorale · University Of Massachusetts Amherst · K22 · FY2022 · CA
SELENIUM--ANTIOXIDANT OR PROOXIDANT MECHANISM
$194,302Texas Tech University Health Scis Center · R01 · FY2001 · CA
Defining a New Role for Alpha-MSH: Antioxidant in UVB-Irradiated Melanocytes
$194,288Ana Luisa Kadekaro · University Of Cincinnati · R21 · FY2011 · ES
Novel targets of treatment for NF1-mutant melanoma
$194,142Iman Osman · New York University School Of Medicine · R21 · FY2022 · CA
Modulating extracellular TCR-CD3 interactions to identify new melanoma immunotherapy targets
$194,142Aswin Natarajan · New York University School Of Medicine · R21 · FY2022 · CA
Informatics, Tissue Resource, and Pathology Core
$194,135Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Immunopheonotyping of circulating tumor cells
$194,119Wafik S El-Deiry · Research Inst Of Fox Chase Can Ctr · R21 · FY2015 · CA
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells
$194,119Alfonso Bellacosa · Research Inst Of Fox Chase Can Ctr · R21 · FY2016 · CA
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
$194,107Joshua R Veatch · Fred Hutchinson Cancer Research Center · K08 · FY2020 · CA
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
$194,107Joshua R Veatch · Fred Hutchinson Cancer Research Center · K08 · FY2021 · CA
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
$194,107Joshua R Veatch · Fred Hutchinson Cancer Center · K08 · FY2023 · CA
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
$194,107Joshua R Veatch · Fred Hutchinson Cancer Center · K08 · FY2022 · CA
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
$194,107Joshua R Veatch · Fred Hutchinson Cancer Center · K08 · FY2024 · CA
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination
$194,090Prabhani Atukorale · University Of Massachusetts Amherst · K22 · FY2023 · CA
CORE 3: Bioinformatics
$194,058Ivan P Gorlov · University Of New Mexico Health Scis Ctr · P01 · FY2018 · CA
Clinically Annotated Human Melanoma for TMEN Research
$194,008Keith T Flaherty · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
$193,991Binfeng Lu · University Of Pittsburgh At Pittsburgh · R21 · FY2014 · CA